Trials / Terminated
TerminatedNCT04180813
Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose
A Non-interventional Study of Patient Medication Adherence and Treatment Effectiveness Among New Users of Linagliptin and Acarbose in the Real-world Clinical Setting in China
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Non-interventional cohort study based on newly collected data under routine medical practice of a total of 500 Diabetes Mellitus, Type 2 patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Linagliptin | drug |
| DRUG | Acarbose | drug |
Timeline
- Start date
- 2020-03-04
- Primary completion
- 2021-07-11
- Completion
- 2021-07-11
- First posted
- 2019-11-29
- Last updated
- 2022-06-23
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04180813. Inclusion in this directory is not an endorsement.